New GMP Certificate Diosite and Moleneind

on .

Resulting from a successful inspection by the Dutch Health Care Inspectorate of our production sites Diosite (Veersemeer/De Geer), Moleneind (Kloosterstraat) and Boxtel (Boseind) from November 19th to November 22nd 2013, we have received a new Certificate of GMP Compliance as manufacturer of active pharmaceutical substances, on our new legal entity Aspen Oss B.V.

Aspen concludes acquisition API business from MSD

on .

Oss, The Netherlands - JSE Limited listed Aspen Holdings, the ninth largest generic pharmaceutical company in the world, announced today that the Aspen Group ("Aspen") has finalized the acquisition of Active Pharmaceutical Ingredients (API) manufacturing operations and related businesses ("the API business") from MSD, known as Merck & Co., Inc. in the US and Canada.

Stephen Saad, Aspen Group Chief Executive, said "this deal strongly complements Aspen's strategic intent